| 28088167
|
Randomized, double-blind, placebo-controlled clinical trial to assess the safety and effectiveness of a novel dual-action oral topical formulation against upper respiratory infections. |
BMC Infect Dis |
2017 |
Mukherjee PK;Esper F;Buchheit K;Arters K;Adkins I;Ghannoum MA;Salata RA |
View
More |
| 32419645
|
Coldzyme(R) Mouth Spray reduces duration of upper respiratory tract infection symptoms in endurance athletes under free living conditions. |
Eur J Sport Sci |
2021 |
Davison G;Perkins E;Jones AW;Swart GM;Jenkins AR;Robinson H;Dargan K |
View
More |
| 34064793
|
Does Trypsin Oral Spray (Viruprotect((R))/ColdZyme((R))) Protect against COVID-19 and Common Colds or Induce Mutation? Caveats in Medical Device Regulations in the European Union. |
Int J Environ Res Public Health |
2021 |
Huijghebaert S;Vanham G;Van Winckel M;Allegaert K |
View
More |
| 36652464
|
Early intervention with ColdZyme mouth spray after self-diagnosis of common cold: A randomized, double-blind, placebo-controlled study. |
PLoS One |
2023 |
Lindberg BF;Nelson I;Ranstam J;Riker DK |
View
More |
